search

Piascledine 300mg box of 30 capsules


€15.45

Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee

48 hours
Qty
In stock

When is Piascledine® 300 prescribed?

This medicine contains a combination of plant extracts.

Medicine based on avocado and soya unsaponifiables indicated for the symptomatic treatment (pain and discomfort during movement) with a delayed effect of osteoarthritis of the knee (Requires a medical diagnosis).

Presentations of the drug Piascledine® 300

PIASCLÉDINE 300 box of 30 capsules.

Also available in boxes of 60 capsules and 90 capsules

Composition of the drug Piascledine® 300

p capsules
Unsaponifiables of avocado oil 100 mg
Unsaponifiables of soybean oil 200 mg

Active ingredients: Unsaponifiables of avocado oil, Unsaponifiables of soya oil

Excipients: Butylated hydroxytoluene, Erythrosine, Yellow iron oxide, Gelatin, Polysorbate 80, Colloidal anhydrous silica, Titanium dioxide

Fertility, pregnancy and lactation

The effect of this drug during pregnancy or lactation is not known. The evaluation of the possible risk related to its use is individual: ask your pharmacist or your doctor for advice.

Instructions for use and dosage of Piascledine® 300

The capsules should be swallowed with a glass of water, in the middle of meals.

Usual dosage:

1 capsule per day.

Advice

In the treatment of osteoarthritis, the effect of this medication is slow to appear: relief generally appears only after 1 to 2 months of treatment.

The drug treatment does not dispense with measures to fight against possible overweight. It is also recommended to practice an adapted physical activity to strengthen the muscles and maintain the mobility of the joint.

Possible side effects of Piascledine® 300

Rare regurgitation with a lipidic smell, allergic reaction.

Diarrhea, stomach pain.

Exceptionally: liver damage.

If you have experienced an adverse reaction that may be due to this medicine, you can report it by downloading the form.

See the Piascledine® 300 leaflet in the "Attached documents" tab

3594135

Specific References